Evidence map›Paper›PMID 30259703›Full record

ArticleJournal of cachexia, sarcopenia and muscle2018

Building strength, endurance, and mobility using an astaxanthin formulation with functional training in elderly.

Sophia Z Liu, Amir S Ali, Matthew D Campbell, Kevin Kilroy, Eric G Shankland, Baback Roshanravan, David J Marcinek, Kevin E Conley

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Mitochondrial Targeted Interventions for Aging.Cold Spring Harbor perspectives in medicine · 2024
    Review
  18. Review
  19. Review
  20. ATP and NADNutrients · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Sophia Z LiuTranslational Center for Metabolic Imaging Department of Radiology, University of Washington, Seattle, WA.
Amir S AliTranslational Center for Metabolic Imaging Department of Radiology, University of Washington, Seattle, WA.
Matthew D CampbellTranslational Center for Metabolic Imaging Department of Radiology, University of Washington, Seattle, WA.
Kevin KilroyTranslational Center for Metabolic Imaging Department of Radiology, University of Washington, Seattle, WA.
Eric G ShanklandTranslational Center for Metabolic Imaging Department of Radiology, University of Washington, Seattle, WA.
Baback RoshanravanDepartment of Medicine, University of Washington, Seattle, WA.
David J MarcinekTranslational Center for Metabolic Imaging Department of Radiology, University of Washington, Seattle, WA.
Kevin E ConleyTranslational Center for Metabolic Imaging Department of Radiology, University of Washington, Seattle, WA.ORCID 0000-0002-2843-5204
University of Washington · US

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
SPECIFICITY OF OXYGEN DNA DAMAGE AND MUTAGENESISP01AG001751 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2021
$29.6M
GENETIC APPROACHES TO AGING RESEARCHT32AG000057 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2019
$14.2M
Skeletal muscle dysfunction in persons with chronic kidney diseaseK23DK099442 · NIDDK · UNIVERSITY OF WASHINGTON · PI ROSHANRAVAN, BABACK · 2013 to 2017
$777k
MR Console UpgradeS10OD016201 · OD · UNIVERSITY OF WASHINGTON · PI CONLEY, KEVIN E · 2013 to 2013
$575k
Mitochondrial bioenergetics in persons with chronic kidney diseaseR03DK114502 · NIDDK · UNIVERSITY OF WASHINGTON · PI ROSHANRAVAN, BABACK · 2018 to 2019
$155k
NCATS NIH HHS UL1 TR000423NCATS NIH HHS UL1 TR002319NIA NIH HHS P01 AG001751NIA NIH HHS T32 AG000057NIDDK NIH HHS K23 DK099442NIDDK NIH HHS R03 DK114502NIH HHS S10 OD016201
6 · The paper itself

Abstract

backgroundBuilding both strength and endurance has been a challenge in exercise training in the elderly, but dietary supplements hold promise as agents for improving muscle adaptation. Here, we test a formulation of natural products (AX: astaxanthin, 12 mg and tocotrienol, 10 mg and zinc, 6 mg) with both anti-inflammatory and antioxidant properties in combination with exercise. We conducted a randomized, double-blind, placebo-controlled study of elderly subjects (65-82 years) on a daily oral dose with interval walking exercise on an incline treadmill.

methodsForty-two subjects were fed AX or placebo for 4 months and trained 3 months (3×/week for 40-60 min) with increasing intervals of incline walking. Strength was measured as maximal voluntary force (MVC) in ankle dorsiflexion exercise, and tibialis anterior muscle size (cross-sectional area, CSA) was determined from magnetic resonance imaging.

resultsGreater endurance (exercise time in incline walking, >50%) and distance in 6 min walk (>8%) accompanied training in both treatments. Increases in MVC by 14.4% (±6.2%, mean ± SEM, P < 0.02, paired t-test), CSA by 2.7% (±1.0%, P < 0.01), and specific force by 11.6% (MVC/CSA, ±6.0%, P = 0.05) were found with AX treatment, but no change was evident in these properties with placebo treatment (MVC, 2.9% ± 5.6%; CSA, 0.6% ± 1.2%; MVC/CSA, 2.4 ± 5.7%; P > 0.6 for all).

conclusionsThe AX formulation improved muscle strength and CSA in healthy elderly in addition to the elevation in endurance and walking distance found with exercise training alone. Thus, the AX formulation in combination with a functional training programme uniquely improved muscle strength, endurance, and mobility in the elderly.

Indexed as

ExerciseGeriatric AssessmentMuscle StrengthPhysical EnduranceWalkingAgedAged, 80 and overAnimalsBody Mass IndexFemaleHumansMagnetic Resonance ImagingMaleMiceMuscle, SkeletalPhysical Conditioning, AnimalastaxanthineXanthophyllsDynapeniaFatigueInterval trainingSarcopeniaSkeletal muscle

Identifiers

PMID30259703
PMCPMC6204600
OpenAlexW2892429583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.